Yaron Naos
Vermogen: 542 725 $ op 30-06-2026
Vermogen: 542 725 $ op 30-06-2026
Yaron Naos is currently Chief Operating Officer at Protalix Biotherapeutics, Inc. since 2026.
Formerly, Mr. Naos was Manager-Product Research & Development at Dexxon Pharmaceuticals Ltd. Education includes an undergraduate degree from Technion-Israel Institute of Technology and an MBA from the University of Haifa.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-04-2026 | 232.929 ( 0,29% ) | 542 725 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Operationeel Directeur | 29-05-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
Dexxon Pharmaceuticals Ltd. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Dexxon Pharmaceuticals Ltd. | |
University of Haifa
University of Haifa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau